BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31166806)

  • 21. Tailored liquid chromatography-mass spectrometry analysis improves the coverage of the intracellular metabolome of HepaRG cells.
    Cuykx M; Negreira N; Beirnaert C; Van den Eede N; Rodrigues R; Vanhaecke T; Laukens K; Covaci A
    J Chromatogr A; 2017 Mar; 1487():168-178. PubMed ID: 28153450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized Metabolomics.
    Marciano DP; Snyder MP
    Methods Mol Biol; 2019; 1978():447-456. PubMed ID: 31119679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A High-Throughput Targeted Metabolomics Workflow for the Detection of 200 Polar Metabolites in Central Carbon Metabolism.
    Cai Y; Zhu ZJ
    Methods Mol Biol; 2019; 1859():263-274. PubMed ID: 30421235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liquid Chromatography-Mass Spectrometry-Based Metabolomics of Nonhuman Primates after 4 Gy Total Body Radiation Exposure: Global Effects and Targeted Panels.
    Pannkuk EL; Laiakis EC; Gill K; Jain SK; Mehta KY; Nishita D; Bujold K; Bakke J; Gahagen J; Authier S; Chang P; Fornace AJ
    J Proteome Res; 2019 May; 18(5):2260-2269. PubMed ID: 30843397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing coverage of the urinary polar metabolome using ultra high-performance hydrophobic interaction liquid chromatography combined with linear and cyclic travelling wave ion mobility and mass spectrometry.
    King A; Gethings LA; Vissers JPC; Plumb RS; Wilson ID
    J Chromatogr A; 2024 Jan; 1714():464537. PubMed ID: 38157664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism.
    Büscher JM; Czernik D; Ewald JC; Sauer U; Zamboni N
    Anal Chem; 2009 Mar; 81(6):2135-43. PubMed ID: 19236023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses.
    Thévenot EA; Roux A; Xu Y; Ezan E; Junot C
    J Proteome Res; 2015 Aug; 14(8):3322-35. PubMed ID: 26088811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of urinary amino-carboxylic metabolites by in-situ heptafluorobutyl chloroformate mediated sample preparation and gas chromatography-mass spectrometry.
    Hušek P; Švagera Z; Hanzlíková D; Řimnáčová L; Zahradníčková H; Opekarová I; Šimek P
    J Chromatogr A; 2016 Apr; 1443():211-32. PubMed ID: 27012787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supercritical fluid chromatography-mass spectrometry using data independent acquisition for the analysis of polar metabolites in human urine.
    Akbal L; Hopfgartner G
    J Chromatogr A; 2020 Jan; 1609():460449. PubMed ID: 31443968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Based on urine metabolomics to study the mechanism of Qi-deficiency affecting type 2 diabetes rats using ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Gao Y; Wu Y; Liu Z; Fu J; Zhang Y; Wu J; Liu S; Song F; Liu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122850. PubMed ID: 34364297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of metabolomic biomarkers for discriminating platinum-sensitive and platinum-resistant ovarian cancer by using GC-MS.
    Eroglu EC; Tunug S; Geckil OF; Gulec UK; Vardar MA; Paydas S
    Eur J Mass Spectrom (Chichester); 2021 Dec; 27(6):235-248. PubMed ID: 34806450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LC-MS/MS analysis of the central energy and carbon metabolites in biological samples following derivatization by dimethylaminophenacyl bromide.
    Willacey CCW; Naaktgeboren M; Lucumi Moreno E; Wegrzyn AB; van der Es D; Karu N; Fleming RMT; Harms AC; Hankemeier T
    J Chromatogr A; 2019 Dec; 1608():460413. PubMed ID: 31395359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
    Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
    Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
    Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid-liquid extraction combined with differential isotope dimethylaminophenacyl labeling for improved metabolomic profiling of organic acids.
    Peng J; Li L
    Anal Chim Acta; 2013 Nov; 803():97-105. PubMed ID: 24216202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GC-MS-based untargeted metabolic profiling of malignant mesothelioma plasma.
    Wang D; Zhu J; Li N; Lu H; Gao Y; Zhuang L; Chen Z; Mao W
    PeerJ; 2023; 11():e15302. PubMed ID: 37220527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analytical Platforms for Mass Spectrometry-Based Metabolomics of Polar and Ionizable Metabolites.
    Macedo AN; Faccio AT; Fukuji TS; Canuto GAB; Tavares MFM
    Adv Exp Med Biol; 2021; 1336():215-242. PubMed ID: 34628634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ingenuity pathways analysis of urine metabolomics phenotypes toxicity of Chuanwu in Wistar rats by UPLC-Q-TOF-HDMS coupled with pattern recognition methods.
    Dong H; Zhang A; Sun H; Wang H; Lu X; Wang M; Ni B; Wang X
    Mol Biosyst; 2012 Apr; 8(4):1206-21. PubMed ID: 22282765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.